Filing Details
- Accession Number:
- 0001387131-18-006855
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-19 20:01:31
- Reporting Period:
- 2018-12-17
- Accepted Time:
- 2018-12-19 20:01:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 25743 | Therapeuticsmd Inc. | TXMD | Pharmaceutical Preparations (2834) | 870233535 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532230 | Iv C.k. John Milligan | 6800 Broken Sound Pkwy Nw, Third Floor Boca Raton FL 33487 | President/Secretary | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-17 | 129,000 | $0.10 | 1,601,419 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-12-17 | 129,000 | $3.75 | 1,472,419 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-12-18 | 129,127 | $0.10 | 1,601,546 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-12-18 | 129,127 | $3.64 | 1,472,419 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-12-17 | 129,000 | $0.00 | 129,000 | $0.10 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-12-18 | 129,127 | $0.00 | 129,127 | $0.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 129,127 | 2012-01-01 | 2019-01-01 | No | 4 | M | Direct |
| 0 | 2012-01-01 | 2019-01-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 434,814 | Indirect | See footnote |
| Common Stock | 3,557,373 | Indirect | See footnote |
Footnotes
- The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.56 to $3.87, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.53 to $3.735, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- By the Milligan Irrevocable Nonexempt Trust - 2014. These securities are held in a trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- By John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.
Billionaire Hedge Funds
